4
Views
0
CrossRef citations to date
0
Altmetric
Symposium Issue: ADVANCES IN HEMATOLOGY

Erythrocyte Antibodies in Autoimmune Hemolytic Anemia

, MD & , MD
Pages 63-69 | Published online: 07 Jul 2016

REFERENCES

  • Costea N, Schwartz R, Constantoulakis M, et al: The use of radioactive antiglobulin for the detection of erythrocyte sensitization. Blood 20:214, 1962
  • Gilliland BC, Baxter E, Evans RS: Red-cell antibodies in acquired hemolytic anemia with negative antiglobulin serum tests. N Engl J Med 285:252, 1971
  • Rosse WF: Fixation of the first component of complement (C'1a) by human antibodies. J Clin Invest 47:2430, 1968
  • Luthringer DG, Jenkins DE Jr, Wallis LA: Autoimmune hemolytic anemia with hemo- globineniia and hemoglobinuria in the absence of demonstrable hemolysis or complement-binding antibody. Vox Sang 16:18, 1969
  • Abramson N, Gelfand EW, Jandl JH, et al: The interaction between human monocytes and red cells: Binding characteristics. J Exp Med 132:1191, 1970
  • Zuelzer WW, Mastrangelo R, Stulberg CS, et al: Autoimmune hemolytic anemia: Natural history and viral-immunologic interactions in childhood. Am J Med 49:80, 1970
  • Strumia PV, Raymond FD: Acquired hemolytic anemia and antipenicillin antibody: Case report and review of the literature. Arch Intern Med 109:603, 1962
  • LoBuglio AF, Jandl JH: The nature of alpha- methyldopa red-cell antibody. N Engl J Med 276:658, 1967
  • Henry RE, Goldberg LS, Sturgeon P, et al: Serologic abnormalities associated with L-dopa therapy. Vox Sang 20:306, 1971
  • Schwartz RS, Costea N: Autoimmune hemolytic anemia: Clinical correlations and biological implications. Semin Hematol 3:2, 1966
  • Costea N, Yakulis V, Heller P: Light-chain heterogeneity of cold agglutinins. Science 152:1520, 1966
  • Ruddy S, Austen KF: C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. J Immunol 107:742, 1971.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.